These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 788293)

  • 1. Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer.
    Jacobo E; Schmidt JD; Weinstein SH; Flocks RH
    Urology; 1976 Sep; 8(3):231-3. PubMed ID: 788293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide therapy for carcinoma of the prostate.
    Airhart RA; Barnett TF; Sullivan JW; Levine RL; Schlegel JU
    South Med J; 1978 Jul; 71(7):798-801. PubMed ID: 78529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced prostatic cancer with flutamide.
    Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
    Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
    [No Abstract]   [Full Text] [Related]  

  • 4. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study.
    Lund F; Rasmussen F
    Br J Urol; 1988 Feb; 61(2):140-2. PubMed ID: 3280080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutamide therapy for advanced prostatic cancer: a phase II study.
    MacFarlane JR; Tolley DA
    Br J Urol; 1985 Apr; 57(2):172-4. PubMed ID: 3986452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
    J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term experience with flutamide in patients with prostatic carcinoma.
    Prout GR; Keating MA; Griffin PP; Schiff SF
    Urology; 1989 Oct; 34(4 Suppl):37-45; discussion 46-56. PubMed ID: 2800092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
    St Arnaud R; Lachance R; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
    Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA; Blumenstein BA; Davis MA; Goodman PJ
    N Engl J Med; 1989 Aug; 321(7):419-24. PubMed ID: 2503724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
    Sogani PC; Whitmore WF
    J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flutamide as primary treatment for metastatic prostatic cancer.
    Lundgren R
    Br J Urol; 1987 Feb; 59(2):156-8. PubMed ID: 3828712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?
    Pavone-Macaluso M; Serretta V; Daricello G; Pavone C; Cacciatore M; Romano C; Cavallo N
    Prog Clin Biol Res; 1990; 350():149-57. PubMed ID: 2201041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of flutamide as monotherapy in the treatment of advanced prostate cancer.
    Newling DW
    Prog Clin Biol Res; 1989; 303():117-21. PubMed ID: 2674980
    [No Abstract]   [Full Text] [Related]  

  • 15. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
    Sarfaty GA; Alder SJ; McLean RG
    Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of combination therapy with flutamide in patients relapsing after castration.
    Labrie F; Dupont A; Giguere M; Borsanyi JP; Lacourciere Y; Monfette G; Emond J; Bergeron N
    Br J Urol; 1988 Apr; 61(4):341-6. PubMed ID: 3289676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.
    Sogani PC; Whitmore WF
    Cancer Treat Res; 1988; 39():131-45. PubMed ID: 2908604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
    Sogani PC; Vagaiwala MR; Whitmore WF
    Cancer; 1984 Aug; 54(4):744-50. PubMed ID: 6378356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide--an antiandrogen inhibiting prostatic cancer and prostatic secretion with retention of potency.
    Stegmayr B; Johansson JE; Schnürer LB
    Med Oncol Tumor Pharmacother; 1988; 5(1):61-5. PubMed ID: 3367673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.
    Schellhammer PF; Sharifi R; Block NL; Soloway MS; Venner PM; Patterson AL; Sarosdy MF; Vogelzang NJ; Chen Y; Kolvenbag GJ
    Cancer; 1996 Nov; 78(10):2164-9. PubMed ID: 8918410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.